FDA Inspection 1049416 — Zhejiang Haisen Pharmaceutical Co., Ltd.
The FDA completed an inspection of Zhejiang Haisen Pharmaceutical Co., Ltd. on April 11, 2018 in Dongyang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- April 11, 2018
- Fiscal Year
- 2018
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Dongyang (China)